0.00Open15.80Pre Close0 Volume0 Open Interest35.00Strike Price0.00Turnover323.39%IV-11.11%PremiumDec 20, 2024Expiry Date17.72Intrinsic Value100Multiplier8DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8902Delta0.0228Gamma0.95Leverage Ratio-0.0888Theta-0.0057Rho-0.85Eff Leverage0.0048Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet